Creative Diagnostics has launched a full range of ready-to-use wild-type and newly emerged mutant SARS-CoV-2 pseudotyped lentiviruses to study the interaction between SARS-CoV-2 spike protein and human ACE2 in a physiologically relevant context.
Our scientists will continue to monitor emerging SARS-CoV-2 variants and produce lentiviral pseudovirus particles accordingly. The Omicron (B.1.1.529) variant is currently in production and should be ready to ship on Tuesday December 22nd if order is submitted before Friday December 17th.
Pseudotyping is available with the wild type or mutant spike proteins from a wide range of coronavirus species
●
Safe to use in BSL-2 labs
●
Unlimited customization options, including the addition of reporter genes for monitoring viral entry
●
Quality-controlled production and use as a critical reagent
Resources
Mouse SARS-CoV-2 IgG1 & IgG2a ELISA Kit
The Mouse SARS-CoV-2 total IgG, IgG1 & IgG2a ELISA kits are designed for evaluating immunogenicity and type of immune response induced by the COVID-19 vaccine in mouse. The increased IgG1/ IgG2a ratio indicates the Th2 type humoral immune response, and the increased IgG2a/IgG1 ratio tends to Th1 type cellular immune response.
In response to the COVID-19 pandemic, Creative Diagnostics is now offering the SARS-CoV-2 nucleoprotein antibody pair for rapid COVID-19 antigen assays to equip healthcare workers for rapid COVID-19 antigen detection. We also offer SARS-CoV-2 antigen extraction buffer tubes that can be used as packing supplies for SARS-CoV-2 antigen extraction.
Coronaviruses are a family of enveloped RNA viruses that infect various mammals as well as birds. Of clinical importance is the Human coronaviruses (HCoVs), which belong to the coronaviridae family. HCoVs have been identified to be a frequent cause of respiratory tract infections, causing mild to severe respiratory diseases.
